University of Glasgow funded projects
| Code | Title | PI | Funding Amount | Partners | Lay Summary | Project Report |
| COV/GLA/20/02 | ASTERIX: adaptive salvage treatment based on endotype-directed anti-virals and immunomodulation – an NHS framework to enable research and clinical trials | Professor Kevin Blyth | £17,000 | CRUK Glasgow CTU NHS GGC |
COV/GLA/20/02 Lay Summary | |
| COV/GLA/20/03 | Glasgow Early Treatment Arm Favipiravir (GETAFIX): a randomised controlled study favipiravir as an early treatment arm of ASTERIX in Covid-19 Hospitalised patients | Dr Janet Scott | £156,510 | NHS GGC University of Strathclyde |
COV/GLA/20/03 Lay Summary | COV/GLA/20/03 Final Report |
| COV/GLA/20/04 | Hypertension, inhibitors of the renin angiotensin system and Covid-19 | Dr Rhain Touyz | £79,846 | COV/GLA/20/04 Lay Summary | COV/GLA/20/04 Final Report | |
| COV/GLA/20/05 | Cardiac Imaging in SARS Coronavirus disease-19 (CISCO-19) | Professor Colin Berry | £47,940 | NHS GGC | COV/GLA/20/05 Lay Summary | COV/GLA/20/05 Final Report |
| COV/GLA/20/06 | CARP: Covid-19 Advanced respiratory physiological platform | Dr Chris Carlin | £123,850 | NHS GGC Altair Medical Storm ID |
COV/GLA/20/06 Lay Summary | COV/GLA/20/06 Final Report |
| COV/GLA/20/07 | Viral and Immunological correlates of clinical severity and response to anti-viral therapy for Covid-19 | Professor Carl Goodyear | £319,473 | NHS GGC | COV/GLA/20/07 Lay Summary | COV/GLA/20/07 Final Report |
| COV/GLA/20/08 | Markers of disease: identifying bacterial secondary infections in Covid-19 patients | Professor Andrew Roe | £56,970 | NHS GGC | COV/GLA/20/08 Lay Summary | |
| COV/GLA/20/11 | Understanding longer term impacts of social distancing and behavioural interventions introduced to prevent the spread of infection in the population | Dr Katie Robb | £37,000 | COV/GLA/20/11 Lay Summary | COV/GLA/20/11 Final Report | |
| COV/GLA/20/12 | Social and health impacts of Covid-19 suppression in vulnerable groups | Professor Sarah Armstrong / Dr Lucy Pickering |
£186,869 | 7 Partner organisations who support the population groups addressed | COV/GLA/20/12 Lay Summary | COV/GLA/20/12 Final Report |